ArriVent BioPharma, Inc. SEC EDGAR Filings (CIK 0001868279)

SEC EDGAR filings, ownership reports, and insider transactions for ArriVent BioPharma, Inc..

Symbol
AVBP on Nasdaq
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
18 Campus Blvd., Suite 100, Newtown Square, PA, 19073-3269
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
ArriVent BioPharma, Inc. has filed 131 SEC EDGAR filings since 23 Jun 2021

Latest Filings

Recent SEC filings for ArriVent BioPharma, Inc. including SCHEDULE 13G/A, 4, SCHEDULE 13G and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 17 Feb 2026 005-94331
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 17 Feb 2026 005-94331
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 04 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 03 Feb 2026 10 Dec 2025
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 30 Jan 2026 005-94331
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 21 Jan 2026 005-94331
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Nov 2025 005-94331
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 10 Nov 2025 30 Sep 2025 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 10 Nov 2025 10 Nov 2025 001-41929
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 05 Nov 2025 005-94331
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 30 Oct 2025 005-94331
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 17 Oct 2025 005-94331
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 15 Oct 2025 005-94331
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 09 Sep 2025 09 Sep 2025 001-41929
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Aug 2025 005-94331
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 13 Aug 2025 005-94331
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 13 Aug 2025 005-94331
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 13 Aug 2025 005-94331
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 11 Aug 2025 30 Jun 2025 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 11 Aug 2025 11 Aug 2025 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 21 Jul 2025 21 Jul 2025 001-41929
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 15 Jul 2025 11 Jul 2025
424B5 Open 424B5 document View SEC filing for 424B5 424B5 02 Jul 2025 333-284661
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 02 Jul 2025 01 Jul 2025 001-41929
424B5 Open 424B5 document View SEC filing for 424B5 424B5 01 Jul 2025 333-284661
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 23 Jun 2025 23 Jun 2025 001-41929
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 20 Jun 2025 18 Jun 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 20 Jun 2025 18 Jun 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 20 Jun 2025 18 Jun 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 20 Jun 2025 18 Jun 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 20 Jun 2025 18 Jun 2025 001-41929
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 15 May 2025 005-94331
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 12 May 2025 31 Mar 2025 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 May 2025 12 May 2025 001-41929
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 29 Apr 2025 28 Apr 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 29 Apr 2025 28 Apr 2025
ARS Open ARS document View SEC filing for ARS ARS 28 Apr 2025 31 Dec 2024 001-41929
DEFA14A Open DEFA14A document View SEC filing for DEFA14A DEFA14A 28 Apr 2025 001-41929
DEF 14A Open DEF 14A document | Open XBRL data View SEC filing for DEF 14A DEF 14A 28 Apr 2025 18 Jun 2025 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 28 Apr 2025 23 Apr 2025 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 13 Mar 2025 11 Mar 2025 001-41929
S-8 Open S-8 document View SEC filing for S-8 FORM S-8 03 Mar 2025 333-285480
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 03 Mar 2025 03 Mar 2025 001-41929
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 03 Mar 2025 31 Dec 2024 001-41929
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 Feb 2025 005-94331
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 14 Feb 2025 03 Feb 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 14 Feb 2025 03 Feb 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 14 Feb 2025 03 Feb 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 14 Feb 2025 03 Feb 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 14 Feb 2025 03 Feb 2025
S-3ASR Open S-3ASR document View SEC filing for S-3ASR S-3ASR 03 Feb 2025 333-284661
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 22 Jan 2025 21 Jan 2025 001-41929
SC 13G Open SC 13G document View SEC filing for SC 13G 04 Dec 2024 005-94331
SC 13G Open SC 13G document View SEC filing for SC 13G ARRIVENT BIOPHARMA, INC. 14 Nov 2024 005-94331
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 14 Nov 2024 30 Sep 2024 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 14 Nov 2024 14 Nov 2024 001-41929
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 12 Nov 2024 005-94331
SC 13G Open SC 13G document View SEC filing for SC 13G 12 Nov 2024 005-94331
SC 13G Open SC 13G document View SEC filing for SC 13G 08 Nov 2024 005-94331
SC 13G Open SC 13G document View SEC filing for SC 13G 24 Oct 2024 005-94331
SC 13G Open SC 13G document View SEC filing for SC 13G 11 Oct 2024 005-94331
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 23 Sep 2024 19 Sep 2024
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 09 Sep 2024 09 Sep 2024 001-41929
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 14 Aug 2024 30 Jun 2024 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 14 Aug 2024 14 Aug 2024 001-41929
8-K/A Open 8-K/A document | Open XBRL data View SEC filing for 8-K/A 8-K/A 09 Jul 2024 16 May 2024 001-41929
8-K/A Open 8-K/A document | Open XBRL data View SEC filing for 8-K/A FORM 8-K/A 09 Jul 2024 20 Apr 2024 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 05 Jun 2024 04 Jun 2024 001-41929
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 20 May 2024 16 May 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 20 May 2024 16 May 2024
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 16 May 2024 16 May 2024 001-41929
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 08 May 2024 31 Mar 2024 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 08 May 2024 08 May 2024 001-41929
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 23 Apr 2024 22 Apr 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 23 Apr 2024 20 Apr 2024
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 22 Apr 2024 20 Apr 2024 001-41929
10-K Open 10-K document View SEC filing for 10-K 10-K 28 Mar 2024 31 Dec 2023 001-41929
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 28 Mar 2024 28 Mar 2024 001-41929
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 13 Feb 2024 005-94331
SC 13D Open SC 13D document View SEC filing for SC 13D SCHEDULE 13D 05 Feb 2024 005-94331
S-8 Open S-8 document View SEC filing for S-8 FORM S-8 02 Feb 2024 333-276840
4 Open 4 document View SEC filing for 4 01 Feb 2024 30 Jan 2024
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 31 Jan 2024 30 Jan 2024
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 31 Jan 2024 30 Jan 2024
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 31 Jan 2024 30 Jan 2024
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 30 Jan 2024 30 Jan 2024 001-41929
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 29 Jan 2024 25 Jan 2024
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 29 Jan 2024 25 Jan 2024
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 26 Jan 2024
424B4 Open 424B4 document View SEC filing for 424B4 424B4 26 Jan 2024 333-276397
EFFECT Open EFFECT document View SEC filing for EFFECT 25 Jan 2024 333-276397
3 Open 3 document View SEC filing for 3 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 25 Jan 2024 25 Jan 2024
S-1MEF Open S-1MEF document View SEC filing for S-1MEF S-1MEF 25 Jan 2024 333-276699
CERT Open CERT document View SEC filing for CERT 25 Jan 2024 001-41929
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 23 Jan 2024 333-276397
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 23 Jan 2024 001-41929
CORRESP Open CORRESP document View SEC filing for CORRESP 23 Jan 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 23 Jan 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 22 Jan 2024
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 22 Jan 2024 333-276397
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 12 Jan 2024 377-06842
CORRESP Open CORRESP document View SEC filing for CORRESP 11 Jan 2024
S-1 Open S-1 document View SEC filing for S-1 S-1 05 Jan 2024 333-276397
DRS/A Open DRS/A document View SEC filing for DRS/A 06 Dec 2023 377-06842
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 05 Dec 2023
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 15 Nov 2023 377-06842
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 31 Oct 2023
DRS/A Open DRS/A document View SEC filing for DRS/A 31 Oct 2023 377-06842
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 18 Oct 2023 377-06842
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 13 Oct 2023
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 04 Oct 2023
DRS/A Open DRS/A document View SEC filing for DRS/A 04 Oct 2023 377-06842
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 27 Sep 2023 377-06842
DRS Open DRS document View SEC filing for DRS 25 Aug 2023 377-06842
D Open D document View SEC filing for D 29 Dec 2022 021-469072
D/A Open D/A document View SEC filing for D/A 14 Feb 2022 021-403969
D Open D document View SEC filing for D 23 Jun 2021 021-403969

About this filer

ArriVent BioPharma, Inc. files with the SEC under CIK 0001868279. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages